Eli Lilly and Company is a
prestigious company university
established in 1876 in United States. It is represented
by 238 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Natural Sciences (62 scientists), Medical and Health Sciences (54 scientists), and Engineering & Technology (13 scientists).
* Total H Index Rankings
Ranking Based
On Selection: 1
psychosis
neurodegeneration
bioinformatics
genomics
drug developmen
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
122
61
0.500
Get Full Access to Premium Data
* Total H Index Rankings
Ranking Based
On Selection: 2
PBPK Models
DDI
CYP
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
79
36
0.456
* Total H Index Rankings
Ranking Based
On Selection: 3
Neuroscience & Drug Discover
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
77
36
0.468
* Total H Index Rankings
Ranking Based
On Selection: 4
GI cancer
translational research
lung cancer
phase 1 trial
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
74
38
0.514
* Total H Index Rankings
Ranking Based
On Selection: 5
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnolog
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
70
55
0.786
* Total H Index Rankings
Ranking Based
On Selection: 6
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
65
38
0.585
* Total H Index Rankings
Ranking Based
On Selection: 7
Neurodegeneration
Neuroscienc
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
63
31
0.492
* Total H Index Rankings
Ranking Based
On Selection: 8
Alzheimer's disease
Neurodegeneration
Drug discover
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
61
37
0.607
* Total H Index Rankings
Ranking Based
On Selection: 9
Osteoporosis
Migraine
Cardiovascular Disease
Drug Developmen
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
35
0.636
* Total H Index Rankings
Ranking Based
On Selection: 10
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulatio
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
25
0.463
Is Your University Ready for the Future?
Compare your institution’s global, national, and city-level ranking with its 20 closest competitors and set strategic goals.
Gain insights from detailed performance analyses of scientists across 13 major disciplines, identify your strengths, improve weaknesses, and gain a competitive edge.. Check Your Free Sample Performance Analysis
* Total H Index Rankings
Ranking Based
On Selection: 11
Diabetes
endocrinology
fatty liver diseas
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
52
23
0.442
* Total H Index Rankings
Ranking Based
On Selection: 12
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacolog
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
50
28
0.560
* Total H Index Rankings
Ranking Based
On Selection: 13
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysi
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
29
0.592
* Total H Index Rankings
Ranking Based
On Selection: 14
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
48
19
0.396
* Total H Index Rankings
Ranking Based
On Selection: 15
Immuno-Oncolog
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
47
34
0.723
* Total H Index Rankings
Ranking Based
On Selection: 16
Heart disease
inflammation
diabetes
noncoding RNAs
systems biolog
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
45
31
0.689
* Total H Index Rankings
Ranking Based
On Selection: 17
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan disease
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
27
0.614
* Total H Index Rankings
Ranking Based
On Selection: 18
Lipoprotein Metabolism and Atherosclerosi
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
26
0.591
* Total H Index Rankings
Ranking Based
On Selection: 19
Alzheimer's diseas
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
38
0.884
* Total H Index Rankings
Ranking Based
On Selection: 20
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
29
0.674
* Total H Index Rankings
Ranking Based
On Selection: 21
Cance
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
22
0.512
* Total H Index Rankings
Ranking Based
On Selection: 22
diabetes
cardiovascular diseases
osteoporosi
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
26
0.619
* Total H Index Rankings
Ranking Based
On Selection: 23
psychopharmamcolog
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
23
0.548
* Total H Index Rankings
Ranking Based
On Selection: 24
Clinical research
patients
methodology
effectiveness
cost-effectivenes
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
21
0.512
* Total H Index Rankings
Ranking Based
On Selection: 25
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
34
0.850
David A Collier
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
122
61
0.500
psychosis
neurodegeneration
bioinformatics
genomics
drug developmen
Stephen Hall
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
79
36
0.456
Christian C Felder
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
77
36
0.468
Neuroscience & Drug Discover
David R Ferry
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
74
38
0.514
Jiye Shi
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
70
55
0.786
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnolog
Eswar Krishnan
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
65
38
0.585
Michael O'Neill
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
63
31
0.492
Martin Citron
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
61
37
0.607
JH Krege
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
35
0.636
Bob Campbell
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
25
0.463
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulatio
Is Your University Ready for the Future?
Compare your institution’s global, national, and city-level ranking with its 20 closest competitors and set strategic goals.
Gain insights from detailed performance analyses of scientists across 13 major disciplines, identify your strengths, improve weaknesses, and gain a competitive edge.. Check Your Free Sample Performance Analysis
Mark L Hartman
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
52
23
0.442
Diabetes
endocrinology
fatty liver diseas
Francis Willard
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
50
28
0.560
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacolog
Tony Zhang
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
29
0.592
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysi
Jonathan A Lee
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
48
19
0.396
Prachi Sharma
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
47
34
0.723
Scot J Matkovich
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
45
31
0.689
Heart disease
inflammation
diabetes
noncoding RNAs
systems biolog
Sreekumar Pillai
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
27
0.614
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan disease
Giacomo Ruotolo
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
26
0.591
Stéphane Epelbaum
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
38
0.884
David H Adams
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
29
0.674
Louis F Stancato
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
22
0.512
Imre Pavo
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
26
0.619
Joel Raskin
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
23
0.548
José Antonio Sacristán
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
21
0.512
Clinical research
patients
methodology
effectiveness
cost-effectivenes
Andrew C Adams
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
34
0.850
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-